VistaGen Therapeutics
VTGN
$4.62
Share price
2.67%
Change (1 day)
3,453.85%
Change (1 year)
Categories
EPS for VistaGen Therapeutics (VTGN)
EPS in 2023 (TTM): -$6.45
According to VistaGen Therapeutics 's latest financial reports the company's current EPS (TTM) is -$6.45. In 2022 the company made an earnings per share (EPS) of -$9.35 an increase over its 2021 EPS that were of -$9.71.
EPS history for VistaGen Therapeutics from 2008 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$6.45 | -31.02% |
| 2022 | -$9.35 | -3.71% |
| 2021 | -$9.71 | 24.49% |
| 2020 | -$7.80 | -55.17% |
| 2019 | -$17.40 | -37.59% |
| 2018 | -$27.88 | -32.16% |
| 2017 | -$41.10 | -72.04% |
| 2016 | -$147.00 | -84.16% |
| 2015 | -$928.20 | 298.71% |
| 2014 | -$232.80 | 83.45% |
| 2013 | -$126.90 | -83.24% |
| 2012 | -$756.97 | 93.91% |
| 2011 | -$390.38 | |
| 2010 | N/A | |
| 2009 | N/A | |
| 2008 | N/A |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -66.20% | 🇺🇸 USA |